| 1 | 81400-08-0 | 1H-Pyrrolizine-2-carbonyl chloride, 1-oxo- (9CI) | C8H4ClNO2 | 181.58 | | |
| 2 | 81400-09-1 | Propanedioic acid, 2-(1H-pyrrol-1-ylmethylene)- | C8H7NO4 | 181.15 | | |
| 3 | 81400-95-5 | 1,2,5-Oxadiazole, 3-methyl-4-(4-nitrophenyl)- | C9H7N3O3 | 205.17 | | |
| 4 | 81401-28-7 | Pyrimidine, 4-chloro-2,6-dimethyl-5-(2-propenyl)- | C9H11ClN2 | 182.65004 | | |
| 5 | 81401-31-2 | 6-(BROMOMETHYL)-2,4-DIMETHYL-5,6-DIHYDROTHIENO[2,3-D]PYRIMIDINE | C9H11BrN2S | | | |
| 6 | 81401-33-4 | Silane, trimethyl[[5-(phenylthio)-1-cyclopenten-1-yl]oxy]- | C14H20OSSi | 264.4585 | | |
| 7 | 81401-34-5 | Cycloheptene, 1-methoxy-7-(phenylthio)- | C14H18OS | 234.35712 | | |
| 8 | 81401-41-4 | Benzoic acid, 3-(acetylamino)-4-(3-methylphenoxy)-, ethyl ester | C18H19NO4 | 313.34776 | | |
| 9 | 81401-52-7 | Benzoic acid, 4-(3-methylphenoxy)-3-[(1-oxopropyl)amino]-, ethyl ester | C19H21NO4 | 327.37434 | | |
| 10 | 81401-53-8 | Benzoic acid, 4-(4-methylphenoxy)-3-[(1-oxopropyl)amino]-, ethyl ester | C19H21NO4 | 327.37434 | | |
| 11 | 81401-54-9 | Benzoic acid, 4-(3-methylphenoxy)-3-[(1-oxobutyl)amino]-, ethyl ester | C20H23NO4 | 341.40092 | | |
| 12 | 81401-57-2 | Benzoic acid, 3-(benzoylamino)-4-(2-methylphenoxy)-, ethyl ester | C23H21NO4 | 375.41714 | | |
| 13 | 81401-58-3 | Benzoic acid, 3-(benzoylamino)-4-(3-methylphenoxy)-, ethyl ester | C23H21NO4 | 375.41714 | | |
| 14 | 81401-59-4 | Benzoic acid, 3-(benzoylamino)-4-(4-methylphenoxy)-, ethyl ester | C23H21NO4 | 375.41714 | | |
| 15 | 81401-61-8 | Benzoic acid, 3-(acetylamino)-4-(2-methoxyphenoxy)-, ethyl ester | C18H19NO5 | 329.34716 | | |
| 16 | 81401-68-5 | Benzoic acid, 3-(benzoylamino)-4-(2-methoxyphenoxy)-, ethyl ester | C23H21NO5 | 391.41654 | | |
| 17 | 81401-69-6 | Benzoic acid, 3-(benzoylamino)-4-(3-methoxyphenoxy)-, ethyl ester | C23H21NO5 | 391.41654 | | |
| 18 | 81402-03-1 | 6-(Bromomethyl)-1,4-naphthalenedione | C11H7BrO2 | 251.08 | | |
| 19 | 81402-04-2 | 1,4-Naphthalenedione, 6-(chloromethyl)- | C11H7ClO2 | 206.62508 | | |
| 20 | 81402-16-6 | Spiro[1H-indene-1,3'-pyrrolidine]-2',5'-dione, 2,3-dihydro- | C12H11NO2 | 201.22 | | |
| 21 | 81402-36-0 | 1-Piperazinepropanamine, gamma-phenyl-N,N,4-trimethyl-, (Z)-2-butenedi oate (1:3) | C16H27N3.3C4H4O4 | 609.625 | | |
| 22 | 81402-38-2 | 1-Piperazinepropanol, 4-(3-(dimethylamino)-1-phenylpropyl)-, (Z)-2-but enedioate (1:3) | C18H31N3O.3C4H4O4 | 653.678 | | |
| 23 | 81402-40-6 | 1-Piperazinepropanamine, N,N-dimethyl-gamma,4-diphenyl-, (Z)-2-butened ioate (1:2) | | | | |
| 24 | 81402-44-0 | 1-(3-Dimethylamino-1-phenylpropyl)-4-(ethoxycarbonyl)piperazine bis(hy drogen maleate) | | | | |
| 25 | 81402-46-2 | 1-Piperidinepropanamine, N,N-dimethyl-gamma-phenyl-, (Z)-2-butenedioat e (1:2) | C16H26N2.2C4H4O4 | 478.539 | | |
| 26 | 81402-48-4 | 1-Piperazinepropanamine, alpha-phenyl-N,N,4-trimethyl-, (Z)-2-butenedi oate (1:3) | C16H27N3.3C4H4O4 | 609.625 | | |
| 27 | 81402-51-9 | 1-(3-Dimethylamino-1-phenylpropyl)-4-(cyclopropylmethyl)piperazine tri s(hydrogen maleate) | | | | |
| 28 | 81402-52-0 | Dapoxetine Impurity 12 | C11H17NO | 179.26 | | |
| 29 | 81402-53-1 | 3-chloro-N,N-dimethyl-1-phenylpropan-1-amine hydrochloride | C11H17Cl2N | 234.16 | 135-137 °C | |
| 30 | 81402-54-2 | 1-(3-Dimethylamino-1-phenylpropyl)piperazine dimaleate | | | | |
| 31 | 81403-03-4 | 4-AMino-2-(phenylaMino)thizole-5-carbonitrile | C10H8N4S | 216.26 | | |
| 32 | 81403-45-4 | Benzenesulfonamide, 2-(1-methylethenyl)- (9CI) | C9H11NO2S | 197.25414 | | |
| 33 | 81403-67-0 | Tetrahydrofuran-2-carboxylic acid (3-methylaminopropyl)amide | C9H18N2O2 | 186.25 | | |
| 34 | 81403-68-1 | Alfuzosine Hydrochloride | C19H28ClN5O4 | 425.91 | 225°C | |
| 35 | 81403-69-2 | N-(4-Amino-6,7-dimethoxyquinazol-2-yl)-N-methylpropylenediamine Hydrochloride | C14H22ClN5O2 | 327.81 | 270°C | |
| 36 | 81403-70-5 | Cyclopentanecarboxamide, N-[3-(methylamino)propyl]- | C10H20N2O | 184.28 | | |
| 37 | 81403-80-7 | Alfuzosin | C19H27N5O4 | 389.45 | 178-180 °C | |
| 38 | 81404-27-5 | 5-(4-methylphenyl)-3-(1-piperidinylmethyl)-1,3,4-oxadiazole-2(3H)-thione | C15H19N3OS | 289.4 | | |
| 39 | 81404-48-0 | 1,2,3-Benzotriazin-4(3H)-one, 3-butoxy- | C11H13N3O2 | 219.23982 | | |
| 40 | 81404-52-6 | Benzenemethanamine, N-hexyl-N-methyl- | C14H23N | 205.33912 | | |
| 41 | 81405-11-0 | 4-diphenylacetoxy-1,1-dimethylpiperidinium | C21H26NO2 | | | |
| 42 | 81405-12-1 | Piperidinium, 4-[(2,2-diphenylacetyl)oxy]-1,1-dimethyl-, 4-methylbenzenesulfonate (1:1) | C28H33NO5S | 495.63 | | |
| 43 | 81405-85-8 | Imazamethabenz-methyl (mixture of isomers) | C16H20N2O3 | 288.34 | 133℃ | |
| 44 | 81406-06-6 | chloracetophon | C6H9Cl4O5P | 333.918421 | | |
| 45 | 81406-37-3 | Fluroxypyr-1-methylheptyl Ester | C15H21Cl2FN2O3 | 367.24 | 59 °C | |
| 46 | 81406-48-6 | sulfoglycolipid A | | | | |
| 47 | 81406-92-0 | Goodyear Pliolite AC4 | | | | |
| 48 | 81406-93-1 | Pliolite AC 80 | | | | |
| 49 | 81407-50-3 | 2(1H)-Pyrimidinone, 4-ethoxytetrahydro-6-methyl- | C7H14N2O2 | 158.19826 | | |
| 50 | 81407-76-3 | 1H,7H-Cyclopropa[c]benzofuran-4,7(3aH)-dione, 1a,2-dihydro-3a-hydroxy-2,2-dimethyl-5-(1-propenyl)-, [1aα,3aβ,5(E),7aS*]- (9CI) | C14H16O4 | 248.27 | | |
| 51 | 81407-92-3 | 4-HYDROXY-2,2-DIMETHYL-BENZOFURAN-3-ONE | C10H10O3 | 178.18 | | |
| 52 | 81408-49-3 | rac erythro-9-(2-Hydroxy-3-nonyl)adenine, Hydrochloride | C14H24ClN5O | 313.82626 | 163-170°C | |
| 53 | 81408-53-9 | Lithium, monohydrate | H2LiO | 24.95628 | | |
| 54 | 81409-74-7 | 6-(2-PROPENYL)-ERGOLINE-8-CARBOXYLIC ACID | C18H20N2O2 | 296.36 | | |
| 55 | 81409-76-9 | (8-beta)-N-(1-Methylethyl)-N-(((1-methylethyl)amino)carbonyl)-6-propyl ergoline-8-carboxamide | | | | |
| 56 | 81409-86-1 | (8-beta)-N-Cyclohexyl-N-((cyclohexylamino)carbonyl)-6-(2-propenyl)ergo line-8-carboxamide | | | | |
| 57 | 81409-90-7 | Cabergoline | C26H37N5O2 | 451.6 | 102-104°C | |
| 58 | 81409-91-8 | (82)-N-[[[3-(Dimethylamino)propyl]amino]carbonyl]-N-ethyl-6-(2-propen-1-yl)-ergoline-8-carboxamide | C26H37N5O2 | 451.6 | | |
| 59 | 81409-92-9 | N-(3-(Dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-n-propylergolin e-8-beta-carboxamide | | | | |